Pentraxin 3 is a stromally-derived biomarker for detection of pancreatic ductal adenocarcinoma
Abstract Pancreatic ductal adenocarcinoma (PDAC), characterized by dense desmoplastic stroma laid down by pancreatic stellate cells (PSC), has no reliable diagnostic biomarkers for timely detection. A multi-center cohort of PDAC patients and controls (chronic pancreatitis, intra-ductal papillary neo...
Guardado en:
Autores principales: | Michelle R. Goulart, Jennifer Watt, Imran Siddiqui, Rita T. Lawlor, Ahmet Imrali, Christine Hughes, Amina Saad, Joanne ChinAleong, Chris Hurt, Catrin Cox, Roberto Salvia, Alberto Mantovani, Tatjana Crnogorac-Jurcevic, Somnath Mukherjee, Aldo Scarpa, Paola Allavena, Hemant M. Kocher |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/e6dda48966e7423ba07476657d983905 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Splice variants as novel targets in pancreatic ductal adenocarcinoma
por: Jun Wang, et al.
Publicado: (2017) -
Complementary Roles of Short and Long Pentraxins in the Complement-Mediated Immune Response to Aspergillus fumigatus Infections
por: Raffaella Parente, et al.
Publicado: (2021) -
Modulation of complement activation by pentraxin-3 in prostate cancer
por: Giovanni Stallone, et al.
Publicado: (2020) -
Is pentraxin 3 level an effective biomarker in disease activity in patients with rheumatoid arthritis?
por: Ozlem Balbaloglu, et al.
Publicado: (2019) -
Gα15 in early onset of pancreatic ductal adenocarcinoma
por: Giulio Innamorati, et al.
Publicado: (2021)